Flammer Martina M.D. sold $262K of INSM
Flammer Martina M.D. (Chief Medical Officer) sold 2,566 shares of INSMED Inc (INSM) at $102.27 ($0.26M total) on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This provides a datapoint on insider activity but does not include new company fundamentals (no earnings, trial, guidance, or deal).
Market read
Traders may monitor insider activity, but the 10b5-1 designation makes the information less likely to drive a durable repricing.
What to watch
The filing does not indicate whether other insiders or institutions are changing positions; it’s one officer’s transaction size and timing.
Background
The article is an SEC Form 4 insider transaction disclosure for INSMED, reported by the company’s Chief Medical Officer.
Ticker impact
INSMED CMO Flammer Martina sold 2,566 shares (~$262.4K) via an open-market transaction under a pre-arranged 10b5-1 plan.
Limited near-term impact; any reaction is likely sentiment-driven and short-lived.
The filing is a routine insider transaction with explicit 10b5-1 pre-arrangement, reducing the probability it reflects new negative information.
Market effects
No clear sector read-through from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Because the sale is pre-arranged under 10b5-1, it may reflect scheduled liquidity needs rather than a view on INSM’s prospects.
Key entities
- issuerINSMED Inc
Public company whose shares were sold by an officer under a 10b5-1 plan.
- insiderFlammer Martina M.D.
Chief Medical Officer who executed the open-market sale.
